The use of delta-tocotrienol and lovastatin for anti-osteoporotic therapy

Life Sciences

Volumn 125, Issue , 2015, Pages 42-48

  Abdul Majeed, Saif ^a   Mohamed, Norazlina ^b   Soelaiman, Ima Nirwana ^b  

^a INTERNATIONAL MEDICAL UNIVERSITY   (Malaysia)

^b UNIVERSITI KEBANGSAAN MALAYSIA   (Malaysia)

Author keywords

Biomechanical test; Bone histomorphometry; Bone strength; HMGCoA reductase; Lovastatin; Osteoporosis; Ovariectomised; Postmenopausal women; Statins; Tocotrienols; Trabecular

Indexed keywords

ALPHA TOCOTRIENOL; DELTA TOCOTRIENOL; MEVINOLIN; UNCLASSIFIED DRUG; ALPHA TOCOPHEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; TOCOTRIENOL, DELTA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOMECHANICS; BONE MASS; BONE STRENGTH; CONTROLLED STUDY; CORTICAL THICKNESS (BONE); DRUG EFFECT; FEMALE; MORPHOMETRICS; NONHUMAN; OSSIFICATION; POSTMENOPAUSE OSTEOPOROSIS; RAT; TRABECULAR BONE; ANALOGS AND DERIVATIVES; ANIMAL; BONE DEVELOPMENT; DRUG EFFECTS; DRUG POTENTIATION; FEMUR; OSTEOPOROSIS; OVARIECTOMY; PATHOLOGY; PATHOPHYSIOLOGY; SPRAGUE DAWLEY RAT;

RATTUS;

ANIMALS; DRUG SYNERGISM; FEMALE; FEMUR; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; LOVASTATIN; OSTEOGENESIS; OSTEOPOROSIS; OVARIECTOMY; RATS; RATS, SPRAGUE-DAWLEY; VITAMIN E;

EID: 84923911970     PISSN: 00243205     EISSN: 18790631     Source Type: Journal    
DOI: 10.1016/j.lfs.2014.12.012     Document Type: Article

References (42)

1. S. Abdul-Majeed, N. Mohamed, and I.-N. Soelaiman Effects of tocotrienol and lovastatin combination on osteoblast and osteoclast activity in estrogen-deficient osteoporosis Evid. Based Complement. Alternat. Med. 2012 2012
2. S. Abdul-Majeed, N. Mohamed, and I.-N. Soelaiman A review on the use of statins and tocotrienols, individually or in combination for the treatment of osteoporosis Curr. Drug Targets 14 13 2013 1579 1590
3. K.-Y. Chin, and S. Ima-Nirwana Vitamin E as an antiosteoporotic agent via receptor activator of nuclear factor kappa-B ligand signaling disruption: current evidence and other potential research areas Evid. Based Complement. Alternat. Med. 2012 2012
4. K.-Y. Chin, and S. Ima-Nirwana Effects of annatto-derived tocotrienol supplementation on osteoporosis induced by testosterone deficiency in rats Clin. Interv. Aging 9 2014 1247 1259
5. K.-Y. Chin, H. Mo, and I.-N. Soelaiman A review of the possible mechanisms of action of tocotrienol - a potential antiosteoporotic agent Curr. Drug Targets 14 13 2013 1533 1541
6. Z.A. Cole, E.M. Dennison, and C. Cooper Osteoporosis epidemiology update Curr. Rheumatol. Rep. 10 2 2008 92 96
7. L. Deng, Y. Ding, Y. Peng, Y. Wu, J. Fan, and W. Li γ-Tocotrienol protects against ovariectomy-induced bone loss via mevalonate pathway as HMG-CoA reductase inhibitor Bone 67 2014 200 207
8. J. Difford A simplified method for the preparation of methyl methacrylate embedding medium for undecalcified bone Med. Lab. Technol 31 1 1974 79 81
9. E. Donnelly Methods for assessing bone quality: a review Clin. Orthop. Relat. Res. 469 8 2011 2128 2138
10. C. Escobar, R. Echarri, and V. Barrios Relative safety profiles of high dose statin regimens Vasc. Health Risk Manag 4 3 2008 525
11. M.A. Estai, F. Suhaimi, A.N. Shuid, S. Das, S. Abdullah, and I.-N. Soelaiman Biomechanical evaluation of fracture healing following administration of Piper sarmentosum in ovariectomised rats Afr. J. Pharm. Pharacol 6 3 2012 144 147
12. M.A. Estai, F. Suhaimi, I.-N. Soelaiman, A.N. Shuid, and S. Das Bone histomorphometric study of young rats following oestrogen deficiency Afr. J. Biotechnol. 10 56 2011 12064 12070
13. S.N. Fathilah, S. Abdullah, N. Mohamed, and A.N. Shuid Labisia pumila prevents complications of osteoporosis by increasing bone strength in a rat model of postmenopausal osteoporosis Evid. Based Complement. Alternat. Med. 2012 2012
14. G. Fernandez, E. Spatz, C. Jablecki, and P. Phillips Statin myopathy: a common dilemma not reflected in clinical trials Cleve. Clin. J. Med. 78 6 2011 393
15. N. Frega, M. Mozzon, and F. Bocci Identification and estimation of tocotrienols in the annatto lipid fraction by gas chromatography-mass spectrometry J. Am. Oil Chem. Soc. 75 12 1998 1723 1727
16. P. Giannoudis, C. Tzioupis, T. Almalki, and R. Buckley Fracture healing in osteoporotic fractures: is it really different?: a basic science perspective Injury 38 1 2007 S90 S99
17. G. Gutierrez, D. Lalka, I. Garrett, G. Rossini, and G. Mundy Transdermal application of lovastatin to rats causes profound increases in bone formation and plasma concentrations Osteoporos. Int. 17 7 2006 1033 1042
18. G.E. Gutierrez, J.R. Edwards, I.R. Garrett, J.S. Nyman, B. McCluskey, and G. Rossini Transdermal lovastatin enhances fracture repair in rats J. Bone Miner. Res. 23 11 2008 1722 1730
19. B.A. Hamelin, and J. Turgeon Hydrophilicity/lipophilicity: relevance for the pharmacology and clinical effects of HMG-CoA reductase inhibitors Trends Pharmacol. Sci. 19 1 1998 26 37
20. Z. Hayatullina, N. Muhammad, N. Mohamed, and I.-N. Soelaiman Virgin coconut oil supplementation prevents bone loss in osteoporosis rat model Evid. Based Complement. Alternat. Med. 2012 2012
21. H. Hermizi, O. Faizah, S. Ima-Nirwana, S.A. Nazrun, and M. Norazlina Beneficial effects of tocotrienol and tocopherol on bone histomorphometric parameters in Sprague-Dawley male rats after nicotine cessation Calcif. Tissue Int. 84 1 2009 65 74
22. M.L. Ho, Y.H. Chen, H.J. Liao, C.H. Chen, S.H. Hung, and M.J. Lee Simvastatin increases osteoblasts and osteogenic proteins in ovariectomized rats Eur. J. Clin. Investig. 39 4 2009 296 303
23. N. Horiuchi, and T. Maeda Statins and bone metabolism Oral Dis. 12 2 2006 85 101
24. F.J. Maritz, M.M. Conradie, P.A. Hulley, R. Gopal, and S. Hough Effect of statins on bone mineral density and bone histomorphometry in rodents Arterioscler. Thromb. Vasc. Biol. 21 10 2001 1636 1641
25. J.A. McAnally, J. Gupta, S. Sodhani, L. Bravo, and H. Mo Tocotrienols potentiate lovastatin-mediated growth suppression in vitro and in vivo Exp. Biol. Med 232 4 2007 523 531
26. H. Mo, H. Yeganehjoo, A. Shah, W.K. Mo, I.N. Soelaiman, and C.-L. Shen Mevalonate-suppressive dietary isoprenoids for bone health J. Nutr. Biochem. 23 12 2012 1543 1551
27. S. Mohamad, A.N. Shuid, S.A. Mokhtar, S. Abdullah, and I.N. Soelaiman Tocotrienol supplementation improves late-phase fracture healing compared to alpha-tocopherol in a rat model of postmenopausal osteoporosis: a biomechanical evaluation Evid. Based Complement. Alternat. Med. 2012 2012
28. N. Muhammad, D.A. Luke, A.N. Shuid, N. Mohamed, and I.-N. Soelaiman Two different isomers of vitamin e prevent bone loss in postmenopausal osteoporosis rat model Evid. Based Complement. Alternat. Med. 2012 2012
29. G. Mundy, R. Garrett, S. Harris, J. Chan, D. Chen, and G. Rossini Stimulation of bone formation in vitro and in rodents by statins Science 286 5446 1999 1946 1949
30. A. Nazrun, M. Norazlina, M. Norliza, and S.I. Nirwana Comparison of the effects of tocopherol and tocotrienol on osteoporosis in animal models Int. J. Pharmacol. 6 5 2010 561 568
31. N.D. Nguyen, H.G. Ahlborg, J.R. Center, J.A. Eisman, and T.V. Nguyen Residual lifetime risk of fractures in women and men J. Bone Miner. Res. 22 6 2007 781 788
32. H. Oxlund, and T.T. Andreassen Simvastatin treatment partially prevents ovariectomy-induced bone loss while increasing cortical bone formation Bone 34 4 2004 609 618
33. H. Oxlund, M. Dalstra, and T.T. Andreassen Statin given perorally to adult rats increases cancellous bone mass and compressive strength Calcif. Tissue Int. 69 5 2001 299 304
34. A.M. Parfitt, M.K. Drezner, F.H. Glorieux, J.A. Kanis, H. Malluche, and P.J. Meunier Bone histomorphometry: standardization of nomenclature, symbols, and units: report of the ASBMR Histomorphometry Nomenclature Committee J. Bone Miner. Res. 2 6 1987 595 610
35. L.G. Raisz Pathogenesis of osteoporosis: concepts, conflicts, and prospects J. Clin. Invest. 115 12 2005 3318 3325
36. B.L. Riggs, S. Khosla, and L.J. Melton III Sex steroids and the construction and conservation of the adult skeleton Endocr. Rev. 23 3 2002 279 302
37. E. Seeman, and P.D. Delmas Bone quality - the material and structural basis of bone strength and fragility N. Engl. J. Med. 354 21 2006 2250 2261
38. I.N. Soelaiman, W. Ming, R. Abu Bakar, N.A. Hashnan, H. Mohd Ali, and N. Mohamed Palm tocotrienol supplementation enhanced bone formation in oestrogen-deficient rats Int. J. Endocrinol. 2012 2012
39. P.W. Sylvester Synergistic anticancer effects of combined γ-tocotrienol with statin or receptor tyrosine kinase inhibitor treatment Genes Nutr 7 1 2012 63 74
40. L.B. Tankó, C. Christiansen, D.A. Cox, M.J. Geiger, M.A. McNabb, and S.R. Cummings Relationship between osteoporosis and cardiovascular disease in postmenopausal women J. Bone Miner. Res. 20 11 2005 1912 1920
41. C.H. Turner Bone strength: current concepts Ann. N. Y. Acad. Sci. 1068 1 2006 429 446
42. W. Yao, R. Farmer, R. Cooper, P. Chmielewski, X. Tian, and R. Setterberg Simvastatin did not prevent nor restore ovariectomy-induced bone loss in adult rats J Musculoskelet. Neuronal Interact. 6 3 2006 277